| Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053) (NCT05314023) | Merck Sharp & Dohme LLC | 2022-05-07 |
| Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts (NCT03948321) | Shanghai Dermatology Hospital | 2019-05-10 |
| Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts (NCT02750202) | University of Pretoria | 2018-07-01 |
| Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response (NCT03296397) | Assistance Publique - Hôpitaux de Paris | 2017-11-15 |
| Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) (NCT03158220) | Merck Sharp & Dohme LLC | 2017-09-20 |
| Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) (NCT02653118) | Merck Sharp & Dohme LLC | 2016-01-22 |
| Topical NVN1000 for the Treatment of External Genital and Perianal Warts (NCT02462187) | Novan, Inc. | 2015-06-12 |
| Long Term Follow-up of HPV Vaccine in HIV (CTN 236) (NCT06915779) | University of British Columbia | 2015-06-01 |
| HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 (NCT02558803) | Regenstrief Institute, Inc. | 2015-02-01 |
| Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) (NCT01796821) | G&E Herbal Biotechnology Co., LTD | 2014-08-01 |
| HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts (NCT02551887) | Regenstrief Institute, Inc. | 2014-02-01 |
| Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) (NCT01651949) | Merck Sharp & Dohme LLC | 2012-10-29 |
| Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment (NCT06700941) | Universidad Nacional de Colombia | 2012-01-01 |
| A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts (NCT01468636) | University of British Columbia | 2011-11-01 |
| SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma (NCT01676792) | National Cheng-Kung University Hospital | 2011-04-01 |
| Typing of Human Papilloma Virus (HPV) From Female Genital Warts (NCT01192282) | University of Cape Town | 2010-04-01 |
| A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) (NCT01047345) | Merck Sharp & Dohme LLC | 2010-02-24 |
| Pharmacokinetic Study of Topically Applied Veregen 15% Compared With Oral Intake of Green Tea Beverage (NCT01082302) | MediGene | 2010-01-01 |
| Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population (NCT00847340) | La Fundacion para la Investigacion y el Desarrollo | 2009-12-01 |
| Alternate Dosing Schedules Study for HPV Vaccine (NCT00862810) | Duke University | 2009-03-01 |
| Alternate Dosing Schedules Study for HPV Vaccine (ADS) (NCT02280642) | Duke University | 2009-03-01 |
| Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts (NCT00735462) | Graceway Pharmaceuticals, LLC | 2008-08-01 |
| Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts (NCT00674739) | Graceway Pharmaceuticals, LLC | 2008-05-01 |
| A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) (NCT00551187) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) (NCT00520598) | Merck Sharp & Dohme LLC | 2007-10-01 |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) (NCT00543543) | Merck Sharp & Dohme LLC | 2007-09-24 |
| Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts (NCT00499967) | Gilead Sciences | 2007-08-01 |
| A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine (NCT00501137) | Simon Dobson | 2007-07-01 |
| Effectiveness Study of Gardasil on Condyloma (NCT01553994) | Lisen Arnheim Dahlstrom | 2006-06-01 |
| Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) (NCT00851643) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts (NCT00189293) | MEDA Pharma GmbH & Co. KG | 2005-06-01 |
| Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016) (NCT00092495) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED) (NCT00092482) | Merck Sharp & Dohme LLC | 2002-06-28 |
| Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015) (NCT00092534) | Merck Sharp & Dohme LLC | 2002-06-14 |
| Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED) (NCT00517309) | Merck Sharp & Dohme LLC | 2001-12-28 |
| Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) (NCT00092521) | Merck Sharp & Dohme LLC | 2001-12-01 |